Leveraging Biophysical Tools to Accelerate RSV Vaccine Development: From Structural Insight to Functional Efficacy

• Establishing the structure and conformational integrity of RSV protein antigens and linking structural state to immunogenicity 
• Applying biophysical tools to characterise stability, aggregation, and conformational dynamics to optimise vaccine candidates early
• Using orthogonal biophysical methods to guide candidate selection, improve manufacturability, and reduce late-stage failure risk

Speakers:

Kan Zhu

Director, Head of Analytical Biochemistry

CSL Seqirus